[HTML][HTML] FDG PET-CT for solitary pulmonary nodule and lung cancer: literature review

D Groheux, G Quere, E Blanc, C Lemarignier… - Diagnostic and …, 2016 - Elsevier
The investigation of solitary pulmonary nodule (SPN) and non-small cell lung cancer
(NSCLC) has rapidly become one of the main indications for 18 F-fluorodeoxyglucose (FDG) …

The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

S Sheikhbahaei, E Mena… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of
FDG PET/CT in treatment response assessment and surveillance of lung cancer and to …

Appropriate use criteria for 18F-FDG PET/CT in restaging and treatment response assessment of malignant disease

H Jadvar, PM Colletti, R Delgado-Bolton… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Precision medicine is evolving to include a variety of data to optimize patient care and
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 …

[HTML][HTML] Present and future roles of FDG-PET/CT imaging in the management of lung cancer

K Kitajima, H Doi, T Kanda, T Yamane… - Japanese Journal of …, 2016 - Springer
Integrated positron emission tomography/computed tomography (PET/CT) using 2-[18 F]
fluoro-2-deoxy-d-glucose (18 F-FDG) has emerged as a powerful tool for combined …

Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis

Y Xiao, L Wang, X Jiang, W She, L He… - Nuclear Medicine …, 2016 - journals.lww.com
Objectives The early detection of suspiciously recurrent breast cancer is of significant
importance. The aim of the present meta-analysis was to evaluate the overall diagnostic …

18F-FDG PET/CT in restaging and evaluation of response to therapy in lung cancer: state of the art

A Castello, S Rossi, E Lopci - Current Radiopharmaceuticals, 2020 - ingentaconnect.com
Background: Metabolic information provided by 18F-FDG PET/CT are useful for initial
staging, therapy planning, response evaluation, and to a lesser extent for the follow-up of …

Follow-up or surveillance 18F-FDG PET/CT and survival outcome in lung cancer patients

AJ Antoniou, C Marcus, AK Tahari… - Journal of Nuclear …, 2014 - Soc Nuclear Med
The value of performing follow-up PET/CT imaging more than 6 mo after the conclusion of
therapy—either as a routine practice or because of clinically suspected recurrence—is not …

Imaging in therapy response assessment and surveillance of lung cancer: evidenced-based review with focus on the utility of 18F-FDG PET/CT

S Sheikhbahaei, F Verde, RK Hales, SP Rowe… - Clinical lung cancer, 2020 - Elsevier
This review covers the state-of-the-art imaging in therapy assessment and surveillance of
lung cancer with focus on the utility of fluorine-18 fluorodeoxyglucose positron emission …

Role of 18F-FDG-PET/CT in establishing new clinical and therapeutic modalities in lung cancer. a short review

RCD Bolton, AK Calapaquí-Terán, F Giammarile… - Revista Española de …, 2019 - Elsevier
Lung cancer is a fairly common malignancy. An early diagnosis and a reliable staging and
re-staging with the aim to detect both local and distant relapse are of utmost importance in …

[HTML][HTML] Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung …

CH Lim, SB Park, HK Kim, YS Choi, J Kim, YC Ahn… - Cancers, 2022 - mdpi.com
Simple Summary Non-small cell lung cancer (NSCLC) patients are at considerable risk of
recurrence or second primary cancer (SPC) after curative therapy. The utility of 18F …